A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon Research437 enrolled

Overview

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

437

Conditions

Open-angle Glaucoma Ocular Hypertension

Interventions

Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspensionDRUG

One drop in the study eye(s) twice daily for 12 months

Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT)DRUG

One drop in the study eye(s) twice daily for 12 months

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older * Diagnosis of open-angle glaucoma or ocular hypertension * Other protocol-defined inclusion criteria may apply Exclusion Criteria: * Under 18 * Pregnant * Other protocol-defined exclusion criteria may apply

Outcomes

Primary Outcomes

Mean IOP

Secondary Outcomes

Percent patients with IOP < 18 mmHg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.